Your browser doesn't support javascript.
loading
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Robertson, James S; Loizides, Ursula; Adisa, Akinola; López de la Rica Manjavacas, Ana; Rodilla, Vicente; Strnadova, Colette; Weisser, Karin; Balocco, Raffaella.
Afiliación
  • Robertson JS; Independent Expert, St Albans, United Kingdom.
  • Loizides U; INN Programme and Classification of Medical Products, INN/HPS/MHP, World Health Organization, 1211 Geneva, Switzerland.
  • Adisa A; Therapeutic Goods Administration, Department of Health, Woden ACT 2606, Australia.
  • López de la Rica Manjavacas A; Agencia Española de Medicamentos y Productos Sanitarios, Madrid 28022, Spain.
  • Rodilla V; Universidad CEU Cardenal Herrera, Alfara del Patriarca, 46113 Valencia, Spain.
  • Strnadova C; Health Canada, Health Products and Food Branch, Ottawa, Ontario K1A 0K9, Canada.
  • Weisser K; Division Safety of Medicinal Products and Medical Devices, Paul-Ehrlich-Institut (Federal Institute for Vaccines and Biomedicines), Paul-Ehrlich-Strasse 7, 63225 Langen, Germany.
  • Balocco R; INN Programme and Classification of Medical Products, INN/HPS/MHP, World Health Organization, 1211 Geneva, Switzerland. Electronic address: baloccor@who.int.
Vaccine ; 40(1): 21-27, 2022 01 03.
Article en En | MEDLINE | ID: mdl-34844820

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido